Medicare Enrolled
Dr. Matthew Hogenmiller, M.D.
Rheumatology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hogenmiller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hogenmiller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hogenmiller
Dr. Matthew Hogenmiller is a rheumatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hogenmiller performed 49,493 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Hogenmiller received a total of $9,693 from 39 pharmaceutical and/or device companies across 501 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hogenmiller is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 23% volume in TX
$9,693 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗49,493
Medicare services
Top 23% in TX for rheumatology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
40,400 | $4 | $15 |
| Denosumab injection (Prolia/Xgeva) | 4,380 | $18 | $69 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
577 | $90 | $377 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
565 | $10 | $32 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
465 | $7 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
453 | $8 | $27 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
450 | $5 | $15 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
448 | $3 | $8 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
283 | $56 | $218 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
200 | $11 | $36 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
168 | $29 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
107 | $116 | $492 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
99 | $4 | $14 |
| Screening test for antibody to noninfectious agent A laboratory test that screens for the presence of antibodies produced in response to a noninfectious agent. |
98 | $11 | $36 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
93 | $17 | $54 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
91 | $12 | $39 |
| Rheumatoid factor level | 86 | $5 | $17 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
75 | $12 | $36 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
68 | $7 | $20 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
67 | $5 | $14 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $63 | $267 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
32 | $6 | $20 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
30 | $2 | $7 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
29 | $11 | $36 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
29 | $10 | $32 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
29 | $13 | $43 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
29 | $9 | $31 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
21 | $3 | $10 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
19 | $13 | $41 |
| Iron level test | 19 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
19 | $9 | $26 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $79 | $331 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$9,693
Total received (2018-2024)
Avg $1,385/year across 7 years
Top 34% in TX for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
501
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,722
2023
$3,016
2022
$1,894
2021
$218
2020
$668
2019
$875
2018
$300
Payments by company (2024)
ABBVIE INC.
$581
Amgen Inc.
$371
UCB, Inc.
$352
PFIZER INC.
$283
E.R. Squibb & Sons, L.L.C.
$173
Lilly USA, LLC
$122
Aurinia Pharma U.S., Inc.
$120
Novartis Pharmaceuticals Corporation
$107
Janssen Biotech, Inc.
$97
Sandoz Inc.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$78
SCILEX PHARMACEUTICALS INC.
$77
Fresenius Kabi USA, LLC
$70
Alexion Pharmaceuticals, Inc.
$51
ANI Pharmaceuticals, Inc.
$42
Mallinckrodt Hospital Products Inc.
$34
Kyowa Kirin, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$22
GlaxoSmithKline, LLC.
$16
Organon Llc
$14
Top 3 companies account for 47.9% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,642
Amgen Inc.
$1,405
PFIZER INC.
$1,017
UCB, Inc.
$954
Lilly USA, LLC
$701
Janssen Biotech, Inc.
$478
Horizon Therapeutics plc
$420
Novartis Pharmaceuticals Corporation
$370
E.R. Squibb & Sons, L.L.C.
$359
Aurinia Pharma U.S., Inc.
$316
Boehringer Ingelheim Pharmaceuticals, Inc.
$229
AbbVie, Inc.
$215
Stryker Corporation
$141
Fresenius Kabi USA, LLC
$136
GlaxoSmithKline, LLC.
$132
AbbVie Inc.
$125
Sandoz Inc.
$121
Genentech USA, Inc.
$98
ANI Pharmaceuticals, Inc.
$86
SCILEX PHARMACEUTICALS INC.
$77
GENZYME CORPORATION
$75
Kiniksa Pharmaceuticals, Ltd.
$63
Organon LLC
$59
AstraZeneca Pharmaceuticals LP
$56
Mallinckrodt Hospital Products Inc.
$52
Alexion Pharmaceuticals, Inc.
$51
Celgene Corporation
$38
Regeneron Healthcare Solutions, Inc.
$37
Celltrion USA Inc.
$34
HOSPIRA, INC.
$28
Merck Sharp & Dohme Corporation
$25
Mylan Institutional Inc.
$24
Radius Health, Inc.
$23
Kyowa Kirin, Inc.
$22
Kiniksa Pharmaceuticals International, plc
$22
Mallinckrodt LLC
$20
Flexion Therapeutics, Inc.
$19
Organon Llc
$14
Purdue Pharma L.P.
$12
Top 3 companies account for 41.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Arcalyst · BENLYSTA · Bimzelx · COSENTYX · CYLTEZO · Cimzia · Crysvita · EVENITY · Enbrel · FORTEO · HADLIMA · HUMIRA · HYRIMOZ · Humira · IDACIO · INFLECTRA · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · LUPKYNIS · LYRICA · OFEV · ORENCIA · OXYCONTIN · PENNSAID · PROPHECY · PURIFIED CORTROPHIN GEL · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Rheumatologists in nearby ZIP areas
99
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hogenmiller is a mixed practice specialist, with above-average Medicare volume (top 23% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hogenmiller experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Hogenmiller performed 40,400 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Hogenmiller receive payments from pharmaceutical companies?
Yes. Dr. Hogenmiller received a total of $9,693 from 39 companies across 501 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hogenmiller's costs compare to other rheumatologists in Dallas?
Dr. Hogenmiller's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hogenmiller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dallas
Browse rheumatologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology